{{Rsnum
|rsid=1106634
|Gene=ATP6V1B2
|Chromosome=8
|position=20208538
|Orientation=plus
|GMAF=0.1919
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ATP6V1B2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.8 | 23.9 | 73.4
| HCB | 0.0 | 27.7 | 72.3
| JPT | 6.3 | 36.9 | 56.8
| YRI | 5.5 | 31.0 | 63.4
| ASW | 12.5 | 23.2 | 64.3
| CHB | 0.0 | 27.7 | 72.3
| CHD | 0.0 | 20.8 | 79.2
| GIH | 2.0 | 25.0 | 73.0
| LWK | 8.3 | 43.1 | 48.6
| MEX | 0.0 | 0.0 | 0.0
| MKK | 2.6 | 30.7 | 66.7
| TSI | 0.0 | 13.0 | 87.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20038947
|Trait=Major depressive disorder (broad)
|Title=Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies
|RiskAllele=A
|Pval=7E-7
|OR=1.30
|ORtxt=[NR]
|OA=1
}}

{{PMID Auto GWAS
|PMID=20889312
|Trait=None
|Title=A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder
|RiskAllele=T
|Pval=0.000004
|OR=1.34
|ORtxt=[NR]
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}